Coverage
Filings
Genmab A/S announced encouraging results from its Phase 1/2 RAINFOL-01 trial for rinatabart sesutecan (Rina-S), an investigational antibody-drug conjugate (ADC), in heavily pretreated patients with advanced endometrial cancer.
| 8 Jun 2006 |
| Genmab, insiders' tradings | 8 Jun 2006 |
| Genmab, articles of association dated May 30, 2006 | 7 Jun 2006 |
| Genmab, Capital Increase in Genmab as a Result of Employee Warrant Exercise | 30 May 2006 |
| Genmab, insiders' tradings | 30 May 2006 |